Say Hello!
Don’t be shy.

   

News

Next-generation yeast strain developer and BioCity client company, Phenotypeca Ltd, has been awarded funding from the Future Vaccine Manufacturing Research Hub (Vax-Hub) to conduct a feasibility study that will exploit the genetic diversity of baker’s yeast to optimise virus-like particles (VLPs) for vaccine production. Vax-Hub launched...

On 27 November, eight innovative start-ups from the Oxford AHSN Accelerator, delivered by BioCity presented their progress and their pitches for future investment to a panel of experts from Oxford AHSN, BioCity and industry. Their pitches were the culmination of the second Oxford AHSN Accelerator programme, delivered by...

BioCity Glasgow based biotechnology company ILC Therapeutics (ILCT) today announced that it has secured significant investment from its first global investor Medical Incubator Japan (MIJ). The Scottish life sciences company, which has received international attention through its work exploring COVID-19 therapeutic treatments with the University...

BioCity based Pharm2Farm (P2F) have developed a coating for textiles which incorporates its proprietary nanoparticles, to give textiles long-lasting virucidal properties. The first application of the technology was to coat a fabric layer in surgical masks and produce a certified antiviral, including Covid-19 and influenza, mask...

BioCity Glasgow based Roylance Pharma, a licensed outsourced controlled storage company dedicated to the life sciences, has partnered with Biocair to provide an end to end fully integrated outsourced storage solution for temperature-controlled pharmaceutical and biological materials. Biocair is a global specialist in life sciences logistics,...

MediCity Glasgow, a medical science business with the aim of generating £5 million has raised £26m and seen the creation of 201 new jobs. Since it was set up five years ago, MediCity Glasgow has helped create 70 new life science and med-tech companies The company supports...